KENS 5: Weekend walk in SA will honor those who battled oral cancer. Here’s how to register.
October 13, 2023
The UT Health San Antonio School of Dentistry and Oral Cancer Foundation is mentioned in this news segment. Watch Now
Newswise: New research led by Mays Cancer Center reveals how mutations in BRCA1 affect cancer susceptibility in women
October 9, 2023
Weixing Zhao, PhD, and Sandeep Burma, PhD, both with the Department of Biochemistry and Structural Biology and the UT Health San Antonio Mays Cancer Center, were quoted in this article. Read More
News-Medical.net: Newly identified protein markers could signal early development of metastatic lung cancer
October 6, 2023
The UT Health San Antonio Mays Cancer Center, along with Josephine Taverna, MD, Department of Medicine, Division of Hematology and Oncology, and Tim Hui-Ming Huang, PhD, chair, Department of Molecular Medicine, were mentioned in this article. Read More
Bollyinside: Early Metastatic Lung Cancer Markers Identified: Potential Breakthrough in Treatment, says Mays Cancer Center Study
October 6, 2023
The UT Health San Antonio Mays Cancer Center, along with Josephine Taverna, MD, Department of Medicine, Division of Hematology and Oncology, and Tim Hui-Ming Huang, PhD, chair, Department of Molecular Medicine, were mentioned in this article. Read More
New research led by Mays Cancer Center reveals how mutations in BRCA1 affect cancer susceptibility in women
October 6, 2023
Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women. The […]
Mays Cancer Center at UT Health San Antonio identifies possible markers for early metastatic lung cancer
October 4, 2023
Researchers at Mays Cancer Center at The University of Texas Health Science at San Antonio have identified protein markers that could signal for early development of metastatic lung cancer, providing possibilities for new treatment. The findings already have led to a five-year, $1.6 million grant from the National Cancer Institute of the National Institutes of […]
